Opendata, web and dolomites
H2020 projects about "liver"
The page lists 188 projects related to the topic "liver".
| # | |||
|---|---|---|---|
| 1 | EuroMix | EuroMix | 2015 |
| 2 | EPoS | Elucidating Pathways of Steatohepatitis | 2015 |
| 3 | CARBALIVE | Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease. | 2015 |
| 4 | FLDcure | A potent Micro-RNA therapeutic for nonalcoholic fatty liver disease (NAFLD) | 2015 |
| 5 | TheLiRep | Exploring the Potential for Therapeutic Lineage Reprogramming of Diabetes | 2015 |
| 6 | Muscle stress relief | Muscle Stress Relief: An integrated research program linking together basic research on secondary myopathies in stress states to innovative translation in applied myology. | 2016 |
| 7 | FIBERSTAR | FIBER-optic sensors for Smart Thermal Ablation at Radiofrequency | 2016 |
| 8 | Brain Metastases | The Role of Circulating Monocytes in the Development of Brain Metastases | 2015 |
| 9 | mini-liver SCCS | Human “mini-liver” stem cell culture systems: from mechanisms behind liver cancer origin and recurrence to new therapeutic treatments | 2016 |
| 10 | TARGEPILIVER | Characterization of Key Epigenetic Targets in Hepatic Fibrosis and Hepatocellular Carcinoma Development. Generation of New Antifibrotic and Antitumoral Drugs. | 2015 |
| 11 | LiVirIn | 3D Liver Organoids: Modelling Host Hepatitis B Virus Interaction | 2015 |
| 12 | REZONABLE | Regeneration and zonation by ZEB2 of Liver Endothelium | 2016 |
| 13 | GLYCODIS3 | Genetic correction of glycogen debranching enzyme deficiency in Glycogen Storage disease III: a proof of concept study | 2016 |
| 14 | EPIRIN | EPIGENETIC REGULATION OF INFLAMMATION IN NAFLD | 2015 |
| 15 | EpiLIVER | Characterization and implications of DNA damage response in liver cancer | 2016 |
| 16 | KCs and Gut Antigens | Elucidating the role of liver resident Kupffer cells in the regulation of the immune responses to intestinal antigens | 2015 |
| 17 | Liver Bioengineering | Ex vivo Re-vascularization in Porcine Liver Bioengineering - A Critical First Step Towards Effective Transplantation of Bioengineered Livers | 2015 |
| 18 | APOBEC | Enzymatic DNA deamination and the immunity/cancer balance | 2015 |
| 19 | HepatoRiSK | A new tumor suppressor role for RSK2 in hepatocellular carcinoma | 2015 |
| 20 | InCisive | creTRAP for in situ Characterization of Fibrosis-Promoting Pathways in Non-alcoholic Fatty Liver Disease | 2016 |
| 21 | Multidyn | Patented advanced low-cost multiwell cell-culture system for in-vitro physiologically relevant biomarker screening | 2015 |
| 22 | Paediatric LMS | Non-Invasive Quantitative Magnetic Resonance for Obese Children – the Paediatric LiverMultiScan Test | 2015 |
| 23 | HBV1 | Innate immune responses to human hepatotropic viral infections | 2015 |
| 24 | Novel asthma therapy | Biocompatible nanoparticles for T cell targeted siRNA delivery as novel asthma therapy | 2015 |
| 25 | EMBRYOandLATERHEALTH | Embryonic origins of cardiovascular health in later life: disentangling early causal pathways in a lifecourse perspective | 2015 |
| 26 | CholangioConcept | Functional in vivo analysis of cholangiocarcinoma development, progression and metastasis. | 2015 |
| 27 | PERIF | Perivascular cells at the crossroads of inflammation, regeneration and fibrosis | 2015 |
| 28 | HEPCIR | Cell circuits as targets and biomarkers for liver disease and cancer prevention | 2016 |
| 29 | EU-ToxRisk | An Integrated European ‘Flagship’ Program Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st Century | 2016 |
| 30 | TETRA | Autologous Stem Cell Seeded Tissue Engineered Trachea | 2016 |
| 31 | DILITEST | Diagnosis and Exclusion of Drug-Induced Liver Injury by using Patient Blood Samples (DILITEST) | 2015 |
| 32 | ImMoRiSt | Immune Monitoring for RIsk STratification in Solid Organ Transplant Recipients | 2016 |
| 33 | BILISTICK | BILISTICK: A low cost point-of-care for early diagnosis of hyperbilirubinemia in newborns | 2016 |
| 34 | HEP-CAR | Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of co-morbidities. | 2016 |
| 35 | UM Cure 2020 | New therapies for uveal melanoma | 2016 |
| 36 | GALAXY | GALAXY: Gut-and-liver axis in alcoholic liver fibrosis | 2016 |
| 37 | FORCE | Imaging the Force of Cancer | 2016 |
| 38 | ChiLTERN | Children’s Liver Tumour European Research Network | 2016 |
| 39 | ENHANCE | Engineering the 3D Niche to enHANCE functionality of hepatocytes derived from human iPSCs | 2016 |
| 40 | DeMILI | NON INVASIVE DIAGNOSTIC TEST SERVICE FOR “NON ALCOHOLIC FATTY LIVER DISEASE” MANAGEMENT | 2016 |
| 41 | CMIL | Crosstalk of Metabolism and Inflammation | 2016 |
| 42 | CollBioImag | Development of a cell-based system for high-throughput screening of antifibrotics | 2016 |
| 43 | EPILIPRO | Elucidating the role of Arid1a in adult liver | 2016 |
| 44 | PDA_TGFb | TGF-beta mediated crosstalk between cancer (stem) cells and tumor microenvironment in pancreatic cancer metastasis | 2017 |
| 45 | MAIT | Evolutionary conserved T cells specific for a microbial metabolite: deciphering their development in the thymus and mapping their interactions with the gut microbiota in vivo. | 2016 |
| 46 | GCG-T3 Dyslipidemia | Validation and Molecular Characterization of Novel Glucagon-Thyroid Hormone Conjugates for the Efficient Management of Dyslipidemia and Fatty Liver Disease | 2016 |
| 47 | ENVERESP | Crosstalk between nuclear envelope and DNA Damage Response: Role of nucleoporin TPR in the maintenance of genomic integrity | 2016 |
| 48 | SiCMetabol | Signaling Cascades in Metabolic Diseases | 2016 |
| 49 | MITOBIOPATH | DISCOVERING NEW DISEASE PATHWAYS AFFECTING mtDNA METABOLISM | 2016 |
| 50 | TransGen RNA | Transgenerational regulation of glucose metabolism by noncoding RNAs | 2016 |
| 51 | Tissue-Tregs | Novel approaches to determining the function of tissue-specific regulatory T cells | 2016 |
| 52 | ICLUb | Regulation of DNA interstrand crosslink repair by ubiquitin. | 2016 |
| 53 | CryoProtect | A new cryoprotectant formulation for the next generation of high throughput screening toxicology tests | 2016 |
| 54 | SugarBlock | Unraveling the protein glycosylation of Plasmodium falciparum is crucial for development of novel therapeutics against malaria | 2016 |
| 55 | DEMETINL | Decisions in metabolic inflammation of the liver: Adhesive interactions involved in leukocyte retention and resolution of inflammation in metabolic-inflammatory liver disease | 2017 |
| 56 | NORMOPERF | Normothermic perfusion devices for renal and hepatic preservation and viability assessment | 2016 |
| 57 | HepatoMetaboPath | Cellular and molecular mechanisms of metabolic immune activation triggering non-alcoholic steatohepatitis (NASH) and HCC | 2016 |
| 58 | INTEGRATE | Central integration of metabolic and hedonic cues in metabolic health | 2016 |
| 59 | ImmunoBile | Bile acid, immune-metabolism, lipid and glucose homeostasis | 2016 |
| 60 | RADIcAL | Non-invasive rapid assessment of chronic liver disease using Magnetic Resonance Imaging with LiverMultiScan | 2016 |
| 61 | INVADIS | Microbial invasion and dissemination within the host, mechanisms and effects | 2016 |
| 62 | OCLD | Tracking the Dynamics of Human Metabolism using Spectroscopy-Integrated Liver-on-Chip Microdevices | 2016 |
| 63 | Relieve-Chol | Reprogramming cell identity to develop new therapies against Cholangiopathies | 2016 |
| 64 | RULLIVER | Rules of self-organization and reengineering of liver tissue | 2016 |
| 65 | ASSIMILES | Advanced Spectroscopy and Spectrometry for Imaging Metabolism using Isotopically-Labeled Endogenous Substrates | 2016 |
| 66 | TGDNL | Mechanisms of cellular fatty acid homeostasis | 2017 |
| 67 | HiPerNav | High Performance Soft-tissue Navigation | 2016 |
| 68 | Foie Gras | Bioenergetic Remodeling in the Pathophysiology and Treatment of Non-Alcoholic Fatty Liver Disease | 2017 |
| 69 | in3 | An integrated interdisciplinary approach to animal-free chemical and nanomaterial safety assessment | 2017 |
| 70 | MOUSIE | Multi-Organ UltraSound-based Inborn Evaluation | 2016 |
| 71 | CONQUEST | CONQUEST: Enabling advanced medical imaging | 2016 |
| 72 | EXNADMINA | EXercise as a regulator of hepatic NAD metabolism and MItochondrial function in Non-Alcoholic fatty liver disease | 2016 |
| 73 | OptoBETA | Multicellular regulation of insulin secretion from pancreatic islets | 2017 |
| 74 | mtFOIE GRAS | mitoFOIE GRAS: Non-invasive Profiling of Mitochondrial Function in Non-Alcoholic Fatty Liver Disease | 2017 |
| 75 | LIVERHOPE | SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS | 2017 |
| 76 | ALIVER | Development of DIALIVE, a novel Liver Dialysis Device for the treatment of patients with Acute on Chronic Liver Failure (ACLF) | 2017 |
| 77 | OptiMalVax | Optimizing a deployable high efficacy malaria vaccine | 2017 |
| 78 | TISuMR | Integrated Tissue Slice Culture and NMR Metabolomics – A Novel Approach Towards SystemicUnderstanding of Liver Function And Disease | 2017 |
| 79 | Reg-Seq | Functional genomics of non-coding mutations in regulatory regions of four metabolic tissues, and their involvement into type 2 diabetes through large-scale sequencing | 2017 |
| 80 | TREATCilia | Novel Therapeutic Avenues for dynein-related Ciliopathies | 2017 |
| 81 | SpheroPredict | A 3D advanced test for prediction of drug response in secondary liver cancer | 2017 |
| 82 | SULIPRO | A scientifically proven, safe, naturally derived drug for the effective treatment of liver damage - an innovative solution for a significant unmet medical need | 2017 |
| 83 | BALXPAND | The HepaRG-Bio-Artificial Liver: Feasibility of commercialization and expansion of business plan | 2017 |
| 84 | Mitomorphosis | Metabolic regulation of mitochondrial morphology | 2017 |
| 85 | LiSDMA | Liver steatosis drives muscle atrophy in type 2 diabetes patients. | 2018 |
| 86 | OPN-Can | Investigating the role of OPN-CD44 in mechanosensitive tumour invasion using biomimetic models | 2017 |
| 87 | TOXANOID | Pharmacological safety testing in human adult stem cell-derived organoids | 2017 |
| 88 | MiRCHOL | Mechanistic and therapeutic implications of microRNA deregulation for drug resistance in bile duct cancer | 2017 |
| 89 | MOOAC | Multi-compartmental Organ-on-a-Chip | 2018 |
| 90 | TransQST | Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030 | 2017 |
| 91 | GrapheneBiosensor | Electrochemical Graphene Sensors as Early Alert Tools for Algal Toxin Detection in Water | 2017 |
| 92 | MEMORIS | Maternal Enteric Microbiota for Offspring's Repertoire development and Illness Susceptibility | 2018 |
| 93 | HBVssNMR | Investigating the structural role of the Hepatitis B virus core protein C-terminal domain in assembly and maturation using solid-state NMR | 2017 |
| 94 | MUSICAL | Chip-based MUSICAL nanoscopy for imaging endocytosis pathways of phage viruses in liver sinusoidal endothelial cells | 2017 |
| 95 | Hepatocarcinoma IVM | Spatiotemporal dynamics of CD8+ T cell responses to hepatocellular carcinoma | 2017 |
| 96 | HEGEMONIC | HEpatocellular carcinoma GErmline MutatiONs ImpaCt (HEGEMONIC) | 2017 |
| 97 | LIVERZAP | Live, In vivo Visualisation of liver Regeneration in Zebrafish After Photoablation of hepatocytes | 2018 |
| 98 | ONCOSYSTEMS | Phenotypic characterization of Liver-derived exosomes populations associated with liver metastasis in pancreatic cancers | 2017 |
| 99 | NAFLDcure | A novel pharmaceutical treatment for nonalcoholic fatty liver disease | 2017 |
| 100 | PRELICAN | Treatment of liver disease and cancer prevention | 2017 |
| 101 | KupfferCellNiche | Determining the instructive tissue signals and the master transcription factors driving Kupffer cell differentiation | 2017 |
| 102 | FATE | Functional Biology of Hepatic CD8+ T cells | 2017 |
| 103 | HEPASPHER | Mimicking liver disease and regeneration in vitro for drug development and liver transplantation | 2017 |
| 104 | DeLIVER | Super-resolution optical microscopy of nanosized pore dynamics in endothelial cells | 2018 |
| 105 | LITMUS | Liver Investigation: Testing Marker Utility in Steatohepatitis | 2017 |
| 106 | New Chol | Development of New therapies against cholangiopathies. | 2017 |
| 107 | CureCN | Adeno-Associated Virus Vector-Mediated Liver Gene Therapy for Crigler-Najjar Syndrome | 2018 |
| 108 | N-IF | The N-IF mouse – a new and unique fibrosis model for preclinical efficacy studies | 2017 |
| 109 | LSO | Liver Spatial Omics | 2018 |
| 110 | HepaCheC | HepaCheC - an in vitro diagnostic assay for the early detection of liver cancer | 2018 |
| 111 | MetaRegulation | Metabolic regulation of metastatic growth | 2018 |
| 112 | ImageToSim | Multiscale Imaging-through-analysis Methods for Autonomous Patient-specific Simulation Workflows | 2019 |
| 113 | ToCCaTa | Tailoring the functional Capacity of Cytotoxic T cells for future Therapies | 2018 |
| 114 | ALPHA-STEM | Advanced Laboratory Phantoms for Soft Tissues in Engineering and Medicine: ALPHA-STEM | 2018 |
| 115 | EnCAge | Progeria models to study endothelial cell ageing: implications for organ regeneration and fibrosis | 2020 |
| 116 | VOLIV | Role of volume-regulated anion channels in liver physiology and metabolism | 2019 |
| 117 | OSTtrans | The Role of OSTα/β as a Bile Acid and Drug Transporter in Obesity-Associated Chronic Liver Disease, Nonalcoholic Fatty Liver Disease | 2018 |
| 118 | GDCOLCA | Understanding gamma delta T cells in colon cancer metastasis | 2018 |
| 119 | PATROLS | Physiologically Anchored Tools for Realistic nanOmateriaL hazard aSsessment | 2018 |
| 120 | PhaseControl | How cellular suicide programmes control phase transitions in fatty liver disease and liver cancer | 2018 |
| 121 | mTORmorS | Role of mTOR signaling dysregulation in the tumor suppressor networks in hepatocellular carcinoma | 2019 |
| 122 | NICI | Non-Invasive Chemistry Imaging in the whole human body | 2018 |
| 123 | AngioMature | Mechanisms of vascular maturation and quiescence during development, homeostasis and aging | 2018 |
| 124 | CTCFStableGenome | CTCF control of genome stability in ageing | 2019 |
| 125 | HepatoPredict | A decision tool for Liver Transplantation based on molecular signature | 2018 |
| 126 | DeLiver | FISH-LIVER-HARVESTER (FLH) Project - an automated fish liver harvesting machine | 2018 |
| 127 | HIPShot | HBV GenetIc and Proteomic Screen | 2019 |
| 128 | CircaCHIP | Development of Circadian Rhythms on Chip | 2018 |
| 129 | EUROoC | Interdisciplinary training network for advancing Organ-on-a-chip technology in Europe | 2018 |
| 130 | mP-CSE | Micro-physiological circadian platform for safety and efficacy assessment of drugs and cosmetics | 2018 |
| 131 | CICURE | Increasing complex I stability as a cure for mitochondrial diseases | 2018 |
| 132 | ElectroPros | Training research pioneers by utilizing and validating the promise of electroporation for minimal invasive oncological treatments. | 2019 |
| 133 | COCLICAN | COllaborative Consortium for the early detection of LIver CANcer | 2018 |
| 134 | STOP | STop Obesity Platform | 2019 |
| 135 | PATH-TOX | Artificial Intelligence to transform Drug and Chemical safety testing | 2018 |
| 136 | VIRUSES AND RNA | RNA regulation during viral infection | 2019 |
| 137 | PoLiMeR | Polymers in the Liver: Metabolism and Regulation | 2018 |
| 138 | EDCMET | Metabolic effects of Endocrine Disrupting Chemicals: novel testing METhods and adverse outcome pathways | 2019 |
| 139 | UPGRADE | Unlocking Precision Gene Therapy | 2019 |
| 140 | TIL-FIT | Increasing the fitness of tumor-infiltrating T cells for cellular immunotherapy | 2019 |
| 141 | BARINAFLD | Using Bariatric Surgery to Discover Weight-Loss Independent Mechanisms Leading to the Reversal of Fatty Liver Disease | 2018 |
| 142 | TransReg | Transgenerational epigenetic inheritance of cardiac regenerative capacity in the zebrafish | 2019 |
| 143 | StopAutoimmunity | Recurrent disease in the liver transplant: window to identify and stop gut signals driving autoimmunity | 2019 |
| 144 | ArtHep | Hepatocytes-Like Microreactors for Liver Tissue Engineering | 2019 |
| 145 | GOLIATH | Beating Goliath: Generation Of NoveL, Integrated and Internationally Harmonised Approaches for Testing Metabolism Disrupting Compounds | 2019 |
| 146 | MICROB-PREDICT | MICROBiome-based biomarkers to PREDICT decompensation of liver cirrhosis and treatment response | 2019 |
| 147 | SECRETE-HF | SECRETED FACTORS IN CARDIAC REMODELING PROVOKE TUMORIGENESIS AND END ORGAN DAMAGE IN HEART FAILURE | 2019 |
| 148 | METAPTPs | PROTEIN TYROSINE PHOSPHATASES IN METABOLIC DISEASES: OXIDATION, DYSFUNCTION AND THERAPEUTIC POTENTIAL | 2019 |
| 149 | IMPACT | Immune Mechanisms of Necrotic DNA Phagocytosis by Neutrophils: A Role for Integrins | 2020 |
| 150 | ChOLLATERAL | Generation of an adverse outcome pathway network on cholestatic liver injury for mechanism-based in vitro testing of chemicals. | 2019 |
| 151 | META2 | METAbolism of bone METAstasis (META2): Metabolic interactions between disseminated breast cancer cells and osteoblast lineage cells drive bone metastases formation | 2019 |
| 152 | MetD-AO | Methyl Donating artificial organelles to support liver cells in Non-alcoholic fatty liver disease | 2019 |
| 153 | AmnioticID | Understanding the identity of the amniotic fluid stem cells | 2019 |
| 154 | Food-PPP-NAFLD | Discovery and characterization of food bioactive compounds modulating the Pentose Phosphate Pathway against non-alcoholic fatty liver disease. | 2019 |
| 155 | UreaCa | Deciphering the metabolic roles of the urea-cycle pathway in carcinogenesis for improving diagnosis and therapy | 2019 |
| 156 | TargetDUBs | Targeting ubiquitin processing in cancer and fibrosis: novel probes for the Ubiquitin Carboxy-Terminal Hydrolases | 2019 |
| 157 | MIRACLE | Metabolic Imaging with RF Antennas to predict Chemotherapy Efficacy | 2019 |
| 158 | ANTHROPOID | Great ape organoids to reconstruct uniquely human development | 2019 |
| 159 | LIV-AD-ON-CHIP | Unmasking insulin resistance triggering mechanisms using microphysiological two-organ systems as in vitro disease models of metabolic syndrome and non-alcoholic fatty liver disease | 2020 |
| 160 | His-Li mouse | His-Li mouse, the unique humanized mouse model resembling human liver and immune systems | 2019 |
| 161 | SIMCARE | SImulation-assisted Minimally invasive CAncer tREatment using the gosmart environment | 2019 |
| 162 | LiverMacRegenCircuit | Elucidating the role of macrophages in liver regeneration and tissue unit formation | 2020 |
| 163 | Hepatic Thermogenesi | Study the functions of the hepatic sympathetic nerve and the receptor Adrb3 in liver-mediated adaptive thermogenesis. | 2019 |
| 164 | ENDOGI | The first multiple stent delivery system for the treatment of biliary, pancreatic and urologic strictures and stenosis | 2019 |
| 165 | CONNECT-2-CLINIC | Pannexin1 nanobodies for the clinical treatment of liver disease | 2020 |
| 166 | WineALaCarte | Commercial appliance for an on-demand & custom reduction of alcohol in wine | 2019 |
| 167 | MetALS | Investigating the pharmacokinetic properties of toxic metals and heat shock proteins as risk factors in Amyotrophic Lateral Sclerosis | 2019 |
| 168 | HEPCAN | A Humanized Monoclonal Anti-Claudin1 Antibody (anti-CLDN1 mAb) for Treatment of Hepatocellular Carcinoma (HCC) | 2019 |
| 169 | PreMeDosE | Precision Medicine via Diagnostic Enzyme Activity Testing | 2020 |
| 170 | BLOC | BENCHTOP NMR FOR LAB-ON-CHIP | 2020 |
| 171 | CYPNASH | Validation of a novel class of cyclophilin inhibitors for the treatment of non-alcoholic steatohepatitis | 2019 |
| 172 | CHANCE | Structure guided inhibition of IDOL to treat atherosclerosis and the metabolic syndrome | 2019 |
| 173 | GuMeCo | Gut-Brain Communication in Metabolic Control | 2020 |
| 174 | MyeFattyLiver | Unravelling the heterogeneity and functions of hepatic myeloid cells in Non-Alcoholic Fatty Liver Disease | 2019 |
| 175 | Oralis | Oralis, The first oral human insulin treatment for Type 2 Diabetes Mellitus | 2019 |
| 176 | BioTrace | World's First Real-Time Monitoring System for Ablation Procedures | 2019 |
| 177 | ORGANTRANS | Controlled Organoids transplantation as enabler for regenerative medicine translation | 2020 |
| 178 | DECISION | DECOMPENSATED CIRRHOSIS: IDENTIFICATION OF NEW COMBINATORIAL THERAPIES BASED ON SYSTEMS APPROACHES | 2020 |
| 179 | LiverScreen | Screening for liver fibrosis - population-based study across European countries | 2020 |
| 180 | PANACHE | Production of next generation modulators of pannexins and connexins as novel therapeutics in the treatment of inflammatory cardiovascular, hepatic and joint diseases. | 2020 |
| 181 | inhibiTOR | Novel selective mTORC1 inhibitors | 2020 |
| 182 | ADVOS | ADVanced Organ Support – Revolution in intensive care for treatment of multiple organ failure | 2019 |
| 183 | FAST_TOX | BANKED HEPATOCYTE MONOLAYERS FOR ACCELERATING DRUG TOXICITY SCREENING | 2020 |
| 184 | METABOLIGHT | Optical imaging platform to unravel metabolic reprogramming of cancer: a path for improved treatments | 2020 |
| 185 | MacinNASH | Revealing the contribution of liver macrophage populations to NASH in insulin resistance | 2020 |
| 186 | Ru4EYE | Ruthenium-based photoactivated chemotherapy against eye cancer | 2020 |
| 187 | MAMBO | Magnetic swArms for liver chemoeMBOlization | 2020 |
| 188 | ONCO-VAX | A multifaceted cancer immunotherapy based on an immune checkpoint-modulating chimeric oncolytic virus vector in combination with a dendritic cell vaccine | 2020 |